1Oosterwegel MA,Greenwald RJ,Mandelbrot DA,et al.CTLA-4 and T cell activation[J].Curr Opin Immunol,1999,11(3):294-300.
2Vahlenkamp TW,Bull ME,Dow JJ,et al.B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis:a model for lentivirus-induced T cell depletion[J].Vet Immunol Immunopathol,2004,98(34):203-214.
3Greenwald RJ,Oosterwegel MA,Woude D,et al.CTLA-4 regulates cell cycle progression during a primary immune response[J].Eur J Immunol,2002,32(2):366-373.
4Sho M,Salama AD,Yamada A,et al.Physiologic regulation of alloimmune responses in vivo:The role of CTLA4 and TH1/TH2 cytokines[J].Transplant Proc,2001,33(7-8):3826-3828.
5Read S,Malmstrom V,Powrie F.Cytotoxic T Lymphocte-associated antigen 4 plays an essential role in the function of regulatory cells that control intestinal inflammation[J].J Exp Med,2000,192(2):295-302.
6Feng YG,Jin YZ,Zhang QY,et al.CTLA4-Fas ligand gene transfer mediated by adenovirus induce long-time survival of murine cardiac allografts[J].Transplant Proc,2005,37(5):2379-2381.
7Ueda H,Howson JM,Esposito L,et al.Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease[J].Nature,2003,423(6939):506-511.
8Deurloo DT,Esch B,Hofstra CL,et al.CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model[J].Am J Respir Cell Mol Biol,2001,25(6):751-760.
9Puppo F,Murdaca G,Ghio M,et al.Emerging biologic drugs for the treatment of rheumatoid arthritis[J].Autoimmun Rev,2005,4(8):537-541.
10Kremer JM,Westhovens R,MD,et al.Treatment of rheumatoid arthritis by selective inhibition of T cell activation with fusion protein CTLA4Ig[J].N Engl J Med,2003,349(20):1907-1915.
3[1]Chui SY,Morse MA,Doldo T,et al.Regulatory and effector T cell subsets and dendritic cells in breast cancer[J].J Clin Onco,2004,22(14):96-97.
4[2]Chen L.Co-inhibitory molecules of the B7-CD28 family in the control of T cell immunity[J].Nat Rev Immunol,2004,4(5):336-347.
5[3]Ueda H,Howson JM,Esposito L,et al.Association of the T cell regulatory gene CTLA4 with susceptibility to autoimmune disease[J].Nature,2003,423(6939):506-511.
6[4]Brunner-Weinzierl MC,Hoff H,Burmester GR.Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses:implications for arthritis and autoimmune diseases[J].Arthritis Res Ther,2004,6(2):45-54.
7[6]Hurwitz AA,Foster BA,Kwon ED,et al.Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade[J].Cancer Res,2000,60(9):2444-2448.
8[7]Peggs KS,Quezada SA,Korman AJ,et al.Principles and use of anti-CTLA4 antibody in human cancer immunotherapy[J].Curr Opin Immunol,2006,18(2):206-213.
9[8]Wang L,Li D,Fu Z,et al.Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population[J].BMC Cancer,2007,10; 7:173.
10[9]Cozar JM,Romero JM,Aptsiauri N,et al.High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer[J].Hum Immunol,2007,68(8):698-704.
